Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types

Clinical & Translational Oncology(2021)10.1007/s12094-021-02677-8Source: DataRank Database

In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types is a research paper published in Clinical & Translational Oncology (2021). On theSindex it has a DataRank of 0. It has been cited 22 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access22 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)OA: hybridTopics (26)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (33)

Tiffany Chang ORCID,Maryl Wright,Hope E. Burks ORCID,S G Elliott ORCID,Rachel A. Sabol ORCID

Live enrichment

PubMed:34370182 PMC:PMC8732292

National Institute of General Medical Sciences

Grant: U54 GM104940

National Institutes of Health

Grant: R01-CA125806-04

National Institutes of Health

Grant: 1R15CA176496-01A1

Novel small molecule inhibitors of MEK5_ERK5 for the treatment of breast cancer

National Institutes of Health

Grant: R01-CA174785-A1

NIGMS NIH HHS

Grant: T34 GM136452

NCI NIH HHS

Grant: R01 CA174785

NIBIB NIH HHS

Grant: T32 EB027632

NCI NIH HHS

Grant: R01 CA125806

NCI NIH HHS

Grant: R15 CA176496

National Institutes of Health

Grant: 3U54GM104940-07S3

Louisiana Clinical and Translational Science Center Supplement - COVID Sequence Surveillance Network

National Institutes of Health

Grant: 5R01CA125806-05

MEK5-Erk5 in breast cancer resistance

National Institutes of Health

Grant: 5R01CA174785-04

Kinase mediated suppression of metastasis in breast cancer

hybridLicense: cc-by

HYBRIDhttps://link.springer.com/content/pdf/10.1007/s12094-021-02677-8.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s12094-021-02677-8.pdf

publisherhttps://link.springer.com/article/10.1007/s12094-021-02677-8/fulltext.html

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8732292

Europe_PMChttps://europepmc.org/articles/PMC8732292

Fields of Study

MedicineBiology03 medical and health sciences0302 clinical medicine

MeSH Terms

AnimalsHumansDisease Models, AnimalAntineoplastic AgentsXenograft Model Antitumor AssaysModels, BiologicalHeterograftsTriple Negative Breast Neoplasms

Keywords

CollagenExtracellular matrixTriple Negative Breast CancerMetaplastic Breast CarcinomaPatient-derived XenograftDisease Models, AnimalAnimalsHeterograftsHumansAntineoplastic AgentsTriple Negative Breast NeoplasmsModels, BiologicalXenograft Model Antitumor AssaysResearch Article

Sustainable Development Goals

SDG 3: 3. Good health

In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types

FAIR Checklist

Authors (33)

Funding (12 grants)

Open Access

Topics

Annotations (Europe PMC)